Medicine and Health

Neutralizing IFNγ Improves Safety without Compromising Efficacy of CAR-T Cell Therapy in B-cell Malignancies

S. Manni, F. D. Bufalo, et al.

Discover groundbreaking research by Simona Manni and colleagues that reveals how IFNγ neutralization with emapalumab can reduce the severe side effects of CAR-T cell therapy, while preserving its effectiveness against B-cell malignancies. This study highlights a promising combination therapy approach that could transform treatment protocols.

00:00

Playback language: English

Related Publications

Explore these studies to deepen your understanding of the subject.

Medicine and Health

CAR T-Cell Therapy for Cancer: Latest Updates and Challenges, with a Focus on B-Lymphoid Malignancies and Selected Solid Tumours

H. K. Tang, C. Tang, et al.

Medicine and Health

Non-viral, specifically targeted CAR-T cells achieve high safety and efficacy in B-NHL

J. Zhang, Y. Hu, et al.

Medicine and Health

Efficacy and safety analysis of TACE + sunitinib vs. sunitinib in the treatment of unresectable advanced renal cell carcinoma: a retrospective study

C. Zheng, H. Lu, et al.

Medicine and Health

CAR-cell therapy in the era of solid tumor treatment: current challenges and emerging therapeutic advances

K. M. Maalej, M. Merhi, et al.

Listen, Learn & Level Up

Over 10,000 hours of research content in 25+ fields, available in 12+ languages.

No more digging through PDFs, just hit play and absorb the world's latest research in your language, on your time.

listen to research audio papers with researchbunny